Aim: To determine the types, severity and evolution of aphasia in unselected, acute stroke patients and evaluate potential predictors for language outcome 1 year after stroke. Methods: 270 acute stroke patients with aphasia (203 with first-ever strokes) were included consecutively and prospectively from three hospitals in Copenhagen, Denmark, and assessed with the Western Aphasia Battery. The assessment was repeated 1 year after stroke. Results: The frequencies of the different types of aphasia in acute first-ever stroke were: global 32%, Broca’s 12%, isolation 2%, transcortical motor 2%, Wernicke’s 16%, transcortical sensory 7%, conduction 5% and anomic 25%. These figures are not substantially different from what has been found in previous studies of more or less selected populations. The type of aphasia always changed to a less severe form during the first year. Nonfluent aphasia could evolve into fluent aphasia (e.g., global to Wernicke’s and Broca’s to anomic), whereas a fluent aphasia never evolved into a nonfluent aphasia. One year after stroke, the following frequencies were found: global 7%, Broca’s 13%, isolation 0%, transcortical motor 1%, Wernicke’s 5%, transcortical sensory 0%, conduction 6% and anomic 29%. The distribution of aphasia types in acute and chronic aphasia is, thus, quite different. The outcome for language function was predicted by initial severity of the aphasia and by the initial stroke severity (assessed by the Scandinavian Stroke Scale), but not by age, sex or type of aphasia. Thus, a scoring of general stroke severity helps to improve the accuracy of the prognosis for the language function. One year after stroke, fluent aphasics were older than nonfluent aphasics, whereas such a difference was not found in the acute phase.

Keywords:
Aphasia, Stroke, Prognosis, Time-course
1.
Pedersen PM: Neuropsychological impairments in stroke: Frequency, time-course, and relevance for rehabilitation; thesis, Hillerød, 1999.
2.
Pedersen PM, Jørgensen HS, Nakayama H, Raaschou HO, Olsen TS: Aphasia in acute stroke: Incidence, determinants, and recovery. Ann Neurol 1995;38:659–666.
3.
Brust JMC, Shafer SQ, Richter RW, Bruun B: Aphasia in acute stroke. Stroke 1976;2:167–174.
4.
Pashek GV, Holland AL: Evolution of aphasia in the first year post-onset. Cortex 1988;24:411–423.
5.
Scarpa M, Colombo A, Sorgato P, De Renzi E: The incidence of aphasia and global aphasia in left brain-damaged patients. Cortex 1987;23:331–336.
6.
Kertesz A, Sheppard A: The epidemiology of aphasic and cognitive impairment in stroke: Age, sex, aphasia type and laterality differences. Brain 1981;104:117–128.
7.
Godefroy O, Dubois C, Debachy B, Leclerc M, Kreisler A: Vascular aphasias. Main characteristics of patients hospitalized in acute stroke units. Stroke 2002;33:702–705.
8.
Lomas J, Kertesz A: Patterns of spontaneous recovery in aphasic groups: A study of adult stroke patients. Brain Lang 1978;5:388–401.
9.
Kertesz A, McCabe P: Recovery patterns and prognosis in aphasia. Brain 1977;100 (pt 1):1–18.
10.
Kauhanen M-L, Korpelainen JT, Hiltunen P, Määttä R, Mononen H, Brusin E, et al: Aphasia, depression, and non-verbal cognitive impairment in ischemic stroke. Cerebrovasc Dis 2000;10:455–461.
11.
Basso A, Bracchi M, Capitani E, Laiacona M, Zanobio ME: Age and evolution of language area functions. A study on adult stroke patients. Cortex 1987;23:475–483.
12.
De Renzi E, Faglioni P, Ferrari P: The influence of sex and age on the incidence and type of aphasia. Cortex 1980;16:627–630.
13.
Lendrem W, Lincoln NB: Spontaneous recovery of language in patients with aphasia between 4 and 34 weeks after stroke. J Neurol Neurosurg Psychiatry 1985;48:743–748.
14.
Miceli G, Caltagirone C, Gainotti G, Masullo C, Silveri MC, Villa G: Influence of age, sex, literacy and pathologic lesion on incidence, severity and type of aphasia. Acta Neurol Scand 1981;64:370–382.
15.
Code C, Rowley D: Age and aphasia type: The interaction of sex, time since onset and handedness. Aphasiology 1987;1:339–345.
16.
Ferro JM, Madureira S: Aphasia type, age and cerebral infarct localisation. J Neurol 1997;244:505–509.
17.
Laska AC, Hellblom A, Murray V, Kahan T, von Arbin M: Aphasia in acute stroke and relation to outcome. J Intern Med 2001;249:413–422.
18.
Kertesz A: Western Aphasia Battery, ed 2. New York, The Psychological Corporation, 1982.
19.
Pedersen PM, Vinter K: Western Aphasia Battery (Danish version). Copenhagen, Psykologisk forlag, 2001.
20.
Lindenstrøm E, Boysen G, Christiansen LW, Rogvi Hansen B, Nielsen BW: Reliability of Scandinavian Stroke Scale. Cerebrovasc Dis 1991;1:103–107.
21.
Scandinavian Stroke Study Group: Multicenter trial of hemodilution in ischemic stroke. Background and study protocol. Stroke 1985;16:885–890.
22.
Jørgensen HS, Plesner A-M, Hübbe P, Larsen K: Marked increase of stroke incidence in men between 1972 and 1990 in Frederiksberg, Denmark. Stroke 1992;23:1701–1704.
23.
Kenin M, Swisher LP: A study of pattern of recovery in aphasia. Cortex 1972;8:56–68.
24.
Vignolo LA: Evolution of aphasia and language rehabilitation: A retrospective explorative study. Cortex 1965;1:344–367.
25.
Basso A, Capitani E, Laiacona M, Luzzatti C: Factors influencing type and severity of aphasia. Cortex 1980;16:631–636.
26.
Demeurisse G, Demol O, Derouck M, De Beuckelaer R, Coekaerts M-J, Capon A: Quantitative study of the rate of recovery from aphasia due to ischemic stroke. Stroke 1980;11:455–458.
27.
Sarno MT, Levita E: Natural course of recovery in severe aphasia. Arch Phys Med Rehabil 1971;52:175–178.
28.
Kimura D: Sex differences in cerebral organization for speech and praxic functions. Can J Psychol 1983;1:19–35.
29.
McGlone J: Sex differences in the cerebral organization of verbal functions in patients with unilateral brain lesions. Brain 1977;100:775–793.
30.
Eslinger PJ, Damasio AR: Age and type of aphasia in patients with stroke. J Neurol Neurosurg Psychiatry 1981;44:377–381.
31.
Obler LK, Albert ML, Goodglass H, Benson DF: Aphasia type and aging. Brain Lang 1978;6:318–322.
32.
Shewan CM, Kertesz A: Effects of speech and language treatment on recovery from aphasia. Brain Lang 1984;23:272–299.
33.
Lendrem W, McGuirk E, Lincoln NB: Factors affecting language recovery in aphasic stroke patients receiving speech therapy. J Neurol Neurosurg Psychiatry 1988;51:1103–1104.
34.
Enderby P, Wood VA, Wade DT, Hewer RL: Aphasia after stroke: A detailed study of recovery in the first 3 months. Int Rehabil Med 1987;8:162–165.
35.
Marshall RC, Phillips DS: Prognosis for improved verbal communication in aphasic stroke patients. Arch Phys Med Rehabil 1983;64:597–600.
36.
Poeck K, Huber W, Willmes K: Outcome of intensive language treatment in aphasia. J Speech Hear Dis 1989;54:471–479.
37.
Sarno MT, Levita E: Recovery in treated aphasia in the first year post-stroke. Stroke 1979;10:663–670.
38.
Holland AL, Greenhouse JB, Fromm D, Swindell CS: Predictors of language restitution following stroke: A multivariate analysis. J Speech Hear Res 1989;32:232–238.
39.
Pickersgill MJ, Lincoln NB: Prognostic indicators and the pattern of recovery of communication in aphasic stroke patients. J Neurol Neurosurg Psychiatry 1983;46:130–139.
40.
Culton GL: Spontaneous recovery from aphasia. J Speech Hear Res 1969;12:825–832.
© 2004 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.